Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?
Gespeichert in:
| Veröffentlicht in: | Stroke (1970) 2006-02, Vol.37 (2), p.336-337 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 337 |
|---|---|
| container_issue | 2 |
| container_start_page | 336 |
| container_title | Stroke (1970) |
| container_volume | 37 |
| creator | Fournier, Albert Choukroun, Gabriel Modeliar, Santhi Samy Godefroy, Olivier Achard, Jean-Michel Wang, Jiguang Messerli, Franz |
| description | |
| doi_str_mv | 10.1161/01.STR.0000199614.67737.e0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70704650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70704650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c404t-7209af39b6fab87f212eca26959b46cccb586a96edce00f0d63bc550957982ed3</originalsourceid><addsrcrecordid>eNpFkc9O3DAQxq2qqGxpX6GyOPSWMLYTO-aCEKV_JBASuz1bjjPpumTjYDtI-w48dENZibnM5ftm5psfIacMSsYkOwNWrjf3JSzFtJasKqVSQpUI78iK1bwqKsmb92QFIHTBK62PyceU_i56Lpr6AzlmUmjFGrEiz98CJpq3SG_v1tdrmqO3A8WUbTv4tKVpnjD6EH3e09DTyw0rIjqccoi0HYJ7wJhoeMJIO7_ddzFM--g7P-KZs4Pz847aMds_YfQpJ-pHmtCFsbNxT1OO4QHpFPEJx-zDePGJHPV2SPj50E_I7-_Xm6ufxc3dj19XlzeFq6DKheKgbS90K3vbNqrnjKOzXOpat5V0zrV1I62W2DkE6KGTonV1DbpWuuHYiRPy9XXuFMPjvIQ1O58cDoMdMczJKFBQyRoW4fmr0MWQUsTeTNHvluMNA_PCwgAzCwvzxsL8Z2HwxfzlsGVud9i9WQ_PF_8A7eKJ4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70704650</pqid></control><display><type>article</type><title>Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Fournier, Albert ; Choukroun, Gabriel ; Modeliar, Santhi Samy ; Godefroy, Olivier ; Achard, Jean-Michel ; Wang, Jiguang ; Messerli, Franz</creator><creatorcontrib>Fournier, Albert ; Choukroun, Gabriel ; Modeliar, Santhi Samy ; Godefroy, Olivier ; Achard, Jean-Michel ; Wang, Jiguang ; Messerli, Franz</creatorcontrib><identifier>ISSN: 0039-2499</identifier><identifier>EISSN: 1524-4628</identifier><identifier>DOI: 10.1161/01.STR.0000199614.67737.e0</identifier><identifier>PMID: 16397183</identifier><language>eng</language><publisher>United States</publisher><subject>Angiotensin II Type 1 Receptor Blockers - therapeutic use ; Apoptosis ; Blood Pressure ; Calcium - antagonists & inhibitors ; Cardiovascular Diseases - pathology ; Dihydropyridines - therapeutic use ; Humans ; Prevalence ; Recurrence ; Risk ; Stroke - drug therapy ; Stroke - pathology ; Stroke - prevention & control ; Time Factors ; Treatment Outcome</subject><ispartof>Stroke (1970), 2006-02, Vol.37 (2), p.336-337</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c404t-7209af39b6fab87f212eca26959b46cccb586a96edce00f0d63bc550957982ed3</citedby><cites>FETCH-LOGICAL-c404t-7209af39b6fab87f212eca26959b46cccb586a96edce00f0d63bc550957982ed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3687,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16397183$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fournier, Albert</creatorcontrib><creatorcontrib>Choukroun, Gabriel</creatorcontrib><creatorcontrib>Modeliar, Santhi Samy</creatorcontrib><creatorcontrib>Godefroy, Olivier</creatorcontrib><creatorcontrib>Achard, Jean-Michel</creatorcontrib><creatorcontrib>Wang, Jiguang</creatorcontrib><creatorcontrib>Messerli, Franz</creatorcontrib><title>Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?</title><title>Stroke (1970)</title><addtitle>Stroke</addtitle><subject>Angiotensin II Type 1 Receptor Blockers - therapeutic use</subject><subject>Apoptosis</subject><subject>Blood Pressure</subject><subject>Calcium - antagonists & inhibitors</subject><subject>Cardiovascular Diseases - pathology</subject><subject>Dihydropyridines - therapeutic use</subject><subject>Humans</subject><subject>Prevalence</subject><subject>Recurrence</subject><subject>Risk</subject><subject>Stroke - drug therapy</subject><subject>Stroke - pathology</subject><subject>Stroke - prevention & control</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0039-2499</issn><issn>1524-4628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc9O3DAQxq2qqGxpX6GyOPSWMLYTO-aCEKV_JBASuz1bjjPpumTjYDtI-w48dENZibnM5ftm5psfIacMSsYkOwNWrjf3JSzFtJasKqVSQpUI78iK1bwqKsmb92QFIHTBK62PyceU_i56Lpr6AzlmUmjFGrEiz98CJpq3SG_v1tdrmqO3A8WUbTv4tKVpnjD6EH3e09DTyw0rIjqccoi0HYJ7wJhoeMJIO7_ddzFM--g7P-KZs4Pz847aMds_YfQpJ-pHmtCFsbNxT1OO4QHpFPEJx-zDePGJHPV2SPj50E_I7-_Xm6ufxc3dj19XlzeFq6DKheKgbS90K3vbNqrnjKOzXOpat5V0zrV1I62W2DkE6KGTonV1DbpWuuHYiRPy9XXuFMPjvIQ1O58cDoMdMczJKFBQyRoW4fmr0MWQUsTeTNHvluMNA_PCwgAzCwvzxsL8Z2HwxfzlsGVud9i9WQ_PF_8A7eKJ4w</recordid><startdate>200602</startdate><enddate>200602</enddate><creator>Fournier, Albert</creator><creator>Choukroun, Gabriel</creator><creator>Modeliar, Santhi Samy</creator><creator>Godefroy, Olivier</creator><creator>Achard, Jean-Michel</creator><creator>Wang, Jiguang</creator><creator>Messerli, Franz</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200602</creationdate><title>Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?</title><author>Fournier, Albert ; Choukroun, Gabriel ; Modeliar, Santhi Samy ; Godefroy, Olivier ; Achard, Jean-Michel ; Wang, Jiguang ; Messerli, Franz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c404t-7209af39b6fab87f212eca26959b46cccb586a96edce00f0d63bc550957982ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Angiotensin II Type 1 Receptor Blockers - therapeutic use</topic><topic>Apoptosis</topic><topic>Blood Pressure</topic><topic>Calcium - antagonists & inhibitors</topic><topic>Cardiovascular Diseases - pathology</topic><topic>Dihydropyridines - therapeutic use</topic><topic>Humans</topic><topic>Prevalence</topic><topic>Recurrence</topic><topic>Risk</topic><topic>Stroke - drug therapy</topic><topic>Stroke - pathology</topic><topic>Stroke - prevention & control</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fournier, Albert</creatorcontrib><creatorcontrib>Choukroun, Gabriel</creatorcontrib><creatorcontrib>Modeliar, Santhi Samy</creatorcontrib><creatorcontrib>Godefroy, Olivier</creatorcontrib><creatorcontrib>Achard, Jean-Michel</creatorcontrib><creatorcontrib>Wang, Jiguang</creatorcontrib><creatorcontrib>Messerli, Franz</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Stroke (1970)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fournier, Albert</au><au>Choukroun, Gabriel</au><au>Modeliar, Santhi Samy</au><au>Godefroy, Olivier</au><au>Achard, Jean-Michel</au><au>Wang, Jiguang</au><au>Messerli, Franz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?</atitle><jtitle>Stroke (1970)</jtitle><addtitle>Stroke</addtitle><date>2006-02</date><risdate>2006</risdate><volume>37</volume><issue>2</issue><spage>336</spage><epage>337</epage><pages>336-337</pages><issn>0039-2499</issn><eissn>1524-4628</eissn><cop>United States</cop><pmid>16397183</pmid><doi>10.1161/01.STR.0000199614.67737.e0</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0039-2499 |
| ispartof | Stroke (1970), 2006-02, Vol.37 (2), p.336-337 |
| issn | 0039-2499 1524-4628 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70704650 |
| source | MEDLINE; American Heart Association Journals; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Angiotensin II Type 1 Receptor Blockers - therapeutic use Apoptosis Blood Pressure Calcium - antagonists & inhibitors Cardiovascular Diseases - pathology Dihydropyridines - therapeutic use Humans Prevalence Recurrence Risk Stroke - drug therapy Stroke - pathology Stroke - prevention & control Time Factors Treatment Outcome |
| title | Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A24%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20the%20MOSES%20trial%20establish%20superiority%20of%20AT1-receptor%20blockers%20over%20dihydropyridine/calcium%20antagonists%20in%20secondary%20stroke%20prevention?&rft.jtitle=Stroke%20(1970)&rft.au=Fournier,%20Albert&rft.date=2006-02&rft.volume=37&rft.issue=2&rft.spage=336&rft.epage=337&rft.pages=336-337&rft.issn=0039-2499&rft.eissn=1524-4628&rft_id=info:doi/10.1161/01.STR.0000199614.67737.e0&rft_dat=%3Cproquest_cross%3E70704650%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70704650&rft_id=info:pmid/16397183&rfr_iscdi=true |